Bioelectronics Corporation
OTC: BIEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Kelly A. Whelan
- Employees
- 9
- Headquarters
- Frederick, United States
- IPO year
- 2004
- Market cap
- $5.4M
- Website
- http://www.bielcorp.com
Loading BIEL…
Loading profile data…Frequently asked questions about BIEL
What does Bioelectronics Corporation (BIEL) do?
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The compa...
Where does BIEL trade?
Bioelectronics Corporation (BIEL) trades on the Other OTC.
What sector is BIEL in?
Bioelectronics Corporation (BIEL) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Bioelectronics Corporation?
Kelly A. Whelan is the chief executive officer of Bioelectronics Corporation (BIEL).
Where is Bioelectronics Corporation headquartered?
Bioelectronics Corporation is headquartered in United States.
Does BIEL pay a dividend?
Bioelectronics Corporation (BIEL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIEL go public?
Bioelectronics Corporation (BIEL) completed its initial public offering in 2004.